Hims falls after FDA posts warning letter

The FDA warned Hims & Hers for misleading ads on compounded weight-loss drugs. Hims claimed "same active ingredient" as FDA-approved drugs like Ozempic, but compounded versions aren't FDA-approved. The FDA says these claims are false and misleading.